Phase 2Recruiting
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial (Psi or Ket)
Psilocybin vs Ketamine for Alcohol Use Disorder
- Sponsor
- University of Iowa (Academic or other)
- Enrollment
- 80 planned
- Conditions
- Alcohol Use Disorder; Alcohol Dependence; Alcohol Abuse
- Interventions
- Psilocybin; Ketamine
- Ages
- adults, older adults
- Registry
- NCT06405607
Full record on ClinicalTrials.gov
From the registry
This study will collect data that measures the effects of a psychedelic intervention on patients struggling with alcohol use disorder (AUD). The study design will be a double blind, randomized, active-comparator trial with two study arms. Subjects randomized to Arm 1 (n=40) will receive individual psychotherapy sessions plus a 30 mg dose of psilocybin. Arm 2 subjects (n=40) will receive individual psychotherapy sessions and a 0.75 mg/kg dose of ketamine.
Primary outcomes
- Timeline Follow-Back for Alcohol to assess change
History
Primary completion expected
Last registry update
Started
Registered